Current Problems in Cardiology
Volume 31, Issue 9 , Pages 557-629 , September 2006

Nuclear Cardiology: Present and Future

  • Raymond R. Russell III, MD, PhD
    • ,
  • Barry L. Zaret, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Barry L. Zaret, MD, Section of Cardiovascular Medicine, Yale University School of Medicine, 333 Cedar Street, FMP 3, New Haven, CT 06510.

References 

  1. Zaret BL , Strauss HW , Martin ND , et al.   Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris . N Engl J Med . 1973;288:809–812
  2. Zaret BL , Stenson RE , Martin ND , et al.   Potassium-43 myocardial perfusion scanning for the noninvasive evaluation of patients with false-positive exercise tests . Circulation . 1973;48:1234–1241
  3. Ishii Y , MacIntyre WJ , Pritchard WH , et al.   Measurement of total myocardial blood flow in dogs with 43K and the scintillation camera . Circ Res . 1973;33:113–122
  4. Botti RE , MacIntyre WJ , Pritchard WH . Identification of ischemic area of left ventricle by visualization of 43 K myocardial deposition . Circulation . 1973;47:486–492
  5. Zaret BL , Pitt B , Ross RS . Determination of the site, extent, and significance of regional ventricular dysfunction during acute myocardial infarction . Circulation . 1972;45:441–456
  6. Bennett KR , Smith RO , Lehan PH , et al.   Correlation of myocardial 42 K uptake with coronary arteriography . Radiology . 1972;102:117–124
  7. Strauss HW , Zaret BL , Hurley PJ , et al.   A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization . Am J Cardiol . 1971;28:575–580
  8. Zaret BL , Strauss HW , Hurley PJ , et al.   A noninvasive scintiphotographic method for detecting regional ventricular dysfunction in man . N Engl J Med . 1971;284:1165–1170
  9. Brindis RG , Douglas PS , Hendel RC , et al.   ACCF/ASNC Appropriateness Criteria for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging (SPECT MPI) (a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology Endorsed by the American Heart Association) . J Am Coll Cardiol . 2005;46:1587–1605
  10. Patel MR , Spertus JA , Brindis RG , et al.   ACCF proposed method for evaluating the appropriateness of cardiovascular imaging . J Am Coll Cardiol . 2005;46:1606–1613
  11. Kiat H , Maddahi J , Roy LT , et al.   Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods . Am Heart J . 1989;117:1–11
  12. Benoit T , Vivegnis D , Lahiri A , et al.   Tomographic myocardial imaging with technetium-99m tetrofosmin. Comparison with tetrofosmin and thallium planar imaging and with angiography . Eur Heart J . 1996;17:635–642
  13. Cramer MJ , van der Wall EE , Verzijlbergen JF , et al.   SPECT versus planar 99mTc-sestamibi myocardial scintigraphy (comparison of accuracy and impact on patient management in chronic ischemic heart disease) . Q J Nucl Med . 1997;41:1–9
  14. Kapur A , Latus KA , Davies G , et al.   A comparison of three radionuclide myocardial perfusion tracers in clinical practice (the ROBUST study) . Eur J Nucl Med Mol Imaging . 2002;29:1608–1616
  15. Acampa W , Cuocolo A , Sullo P , et al.   Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease . J Nucl Cardiol . 1998;5:265–274
  16. Turgut B , Unlu M , Cengel A . Dobutamine stress tetrofosmin SPECT; evaluation of short rest-stress protocol and head to head comparison with MIBI in detection of coronary artery disease . Ann Nucl Med . 2005;19:115–122
  17. Soman P , Taillefer R , DePuey EG , et al.   Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease . J Am Coll Cardiol . 2001;37:458–462
  18. Tartagni F , Dondi M , Limonetti P , et al.   Dipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels (comparison with thallium-201 stress-rest study) . J Nucl Med . 1991;32:369–376
  19. Dondi M , Monetti N , Levorato M , et al.   Diagnostic accuracy of single photon emission computed tomography with thallium-201 for the identification of diseased coronary arteries. Comparison between dipyridamole infusion and exercise stress test . J Nucl Med Allied Sci . 1990;34:19–23
  20. Huikuri HV , Korhonen UR , Airaksinen J , et al.   Comparison of dipyridamole-handgrip test and bicycle exercise test for thallium tomographic imaging . Am J Cardiol . 1988;61:264–268
  21. Gupta NC , Esterbrooks DJ , Hilleman DE , et al.  The GE SPECT Multicenter Adenosine Study Group   Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging . J Am Coll Cardiol . 1992;19:248–257
  22. Nguyen T , Heo J , Ogilby JD , et al.   Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia (correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography) . J Am Coll Cardiol . 1990;16:1375–1383
  23. LaManna MM , Mohama R , Slavich IL , et al.   Intravenous adenosine (adenoscan) versus exercise in the noninvasive assessment of coronary artery disease by SPECT . Clin Nucl Med . 1990;15:804–805
  24. Coyne EP , Belvedere DA , Vande Streek PR , et al.   Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease . J Am Coll Cardiol . 1991;17:1289–1294
  25. Nishimura S , Mahmarian JJ , Boyce TM , et al.   Equivalence between adenosine and exercise thallium-201 myocardial tomography (a multicenter, prospective, crossover trial) . J Am Coll Cardiol . 1992;20:265–275
  26. Marwick T , Willemart B , D’Hondt AM , et al.   Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography . Circulation . 1993;87:345–354
  27. Cuocolo A , Nicolai E , Soricelli A , et al.   Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease (comparison between adenosine and dynamic exercise stress testing) . J Nucl Cardiol . 1996;3:194–203
  28. Burns RJ , Galligan L , Wright LM , et al.   Improved specificity of myocardial thallium-201 single-photon emission computed tomography in patients with left bundle branch block by dipyridamole . Am J Cardiol . 1991;68:504–508
  29. Vaduganathan P , He ZX , Raghavan C , et al.   Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block (exercise, adenosine or dobutamine imaging?) . J Am Coll Cardiol . 1996;28:543–550
  30. Mahmood S , Gupta NK , Gunning M , et al.   201Tl myocardial perfusion SPET (adenosine alone or combined with dynamic exercise) . Nucl Med Commun . 1994;15:586–592
  31. Cramer MJ , Verzijlbergen JF , van der Wall EE , et al.   Comparison of adenosine and high-dose dipyridamole both combined with low-level exercise stress for 99Tcm-MIBI SPET myocardial perfusion imaging . Nucl Med Commun . 1996;17:97–104
  32. Samady H , Wackers FJ , Joska TM , et al.   Pharmacologic stress perfusion imaging with adenosine (role of simultaneous low-level treadmill exercise) . J Nucl Cardiol . 2002;9:188–196
  33. Udelson JE , Heller GV , Wackers FJ , et al.   Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging . Circulation . 2004;109:457–464
  34. Hendel RC , Bateman TM , Cerqueira MD , et al.   Initial Clinical experience with Regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging . J Am Coll Cardiol . 2005;46:2069–2075
  35. Hays JT , Mahmarian JJ , Cochran AJ , et al.   Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing . J Am Coll Cardiol . 1993;21:1583–1590
  36. Voth E , Baer FM , Theissen P , et al.   Dobutamine 99mTc-MIBI single-photon emission tomography (non-exercise-dependent detection of haemodynamically significant coronary artery stenoses) . Eur J Nucl Med . 1994;21:537–544
  37. Elhendy A , Sozzi FB , Valkema R , et al.   Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity . J Nucl Cardiol . 2000;7:649–654
  38. Herman SD , LaBresh KA , Santos-Ocampo CD , et al.   Comparison of dobutamine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease . Am J Cardiol . 1994;73:164–169
  39. Marwick TH , D’Hondt AM , Mairesse GH , et al.   Comparative ability of dobutamine and exercise stress in inducing myocardial ischaemia in active patients . Br Heart J . 1994;72:31–38
  40. Geleijnse ML , Elhendy A , van Domburg RT , et al.   Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain . Am J Cardiol . 1996;77:1057–1061
  41. Kiat H , Iskandrian AS , Villegas BJ , et al.   Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy . The International Arbutamine Study Group J Am Coll Cardiol . 1995;26:1159–1167
  42. Shehata AR , Ahlberg AW , Gillam LD , et al.   Direct comparison of arbutamine and dobutamine stress testing with myocardial perfusion imaging and echocardiography in patients with coronary artery disease . Am J Cardiol . 1997;80:716–720
  43. Wright DJ , Williams SG , Lindsay HS , et al.   Assessment of adenosine, arbutamine and dobutamine as pharmacological stress agents during (99m)Tc-tetrofosmin SPECT imaging (a randomized study) . Nucl Med Commun . 2001;22:1305–1311
  44. Anagnostopoulos C , Pennell D , Francis J , et al.   A comparison of adenosine and arbutamine for myocardial perfusion imaging . Eur J Nucl Med . 1998;25:394–400
  45. Milcinski M , Henze E , Lietzenmayer R , et al.   Reproducibility of quantitative hexakis-2-methoxyisobutylisonitrile single photon emission tomography in stable coronary artery disease . Eur J Nucl Med . 1991;18:17–22
  46. Mahmarian JJ , Moye LA , Verani MS , et al.   High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography . Am J Cardiol . 1995;75:1116–1119
  47. Germano G , Kavanagh PB , Waechter P , et al.   A new algorithm for the quantitation of myocardial perfusion SPECT. I: technical principles and reproducibility . J Nucl Med . 2000;41:712–719
  48. Tamaki N , Yonekura Y , Mukai T , et al.   Stress thallium-201 transaxial emission computed tomography (quantitative versus qualitative analysis for evaluation of coronary artery disease) . J Am Coll Cardiol . 1984;4:1213–1221
  49. DePasquale EE , Nody AC , DePuey EG , et al.   Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease . Circulation . 1988;77:316–327
  50. Mahmarian JJ , Boyce TM , Goldberg RK , et al.   Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease . J Am Coll Cardiol . 1990;15:318–329
  51. Mowatt G , Brazzelli M , Gemmell H , et al.   Systematic review of the prognostic effectiveness of SPECT myocardial perfusion scintigraphy in patients with suspected or known coronary artery disease and following myocardial infarction . Nucl Med Commun . 2005;26:217–229
  52. Iskander S , Iskandrian AE . Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging . J Am Coll Cardiol . 1998;32:57–62
  53. Marie PY , Danchin N , Durand JF , et al.   Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data . J Am Coll Cardiol . 1995;26:879–886
  54. Machecourt J , Longere P , Fagret D , et al.   Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. Study in 1,926 patients with follow-up at 33 months . J Am Coll Cardiol . 1994;23:1096–1106
  55. Schinkel AF , Elhendy A , Biagini E , et al.   Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing . J Nucl Med . 2005;46:12–18
  56. Shaw LJ , Hendel R , Borges-Neto S , et al.   Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging (results from the multicenter registry of 4,728 patients) . J Nucl Med . 2003;44:134–139
  57. Hachamovitch R , Hayes S , Friedman JD , et al.   Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans (what is the warranty period of a normal scan?) . J Am Coll Cardiol . 2003;41:1329–1340
  58. Alkeylani A , Miller DD , Shaw LJ , et al.   Influence of race on the prediction of cardiac events with stress technetium-99m sestamibi tomographic imaging in patients with stable angina pectoris . Am J Cardiol . 1998;81:293–297
  59. Elhendy A , Schinkel AF , van Domburg RT , et al.   Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction (impact of scintigraphic extent of coronary artery disease) . J Nucl Cardiol . 2004;11:704–709
  60. Leslie WD , Tully SA , Yogendran MS , et al.   Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging . J Nucl Med . 2005;46:204–211
  61. Hachamovitch R , Hayes SW , Friedman JD , et al.   A prognostic score for prediction of cardiac mortality risk after adenosine stress myocardial perfusion scintigraphy . J Am Coll Cardiol . 2005;45:722–729
  62. Hachamovitch R , Berman DS , Shaw LJ , et al.   Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death (differential stratification for risk of cardiac death and myocardial infarction) . Circulation . 1998;97:535–543
  63. Borges-Neto S , Shaw LK , Tuttle RH , et al.   Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease . Am J Cardiol . 2005;95:182–188
  64. Hachamovitch R , Hayes SW , Friedman JD , et al.   Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography . Circulation . 2003;107:2900–2907
  65. Elhendy A , Schinkel AF , van Domburg RT , et al.   Incidence and predictors of heart failure during long-term follow-up after stress Tc-99m sestamibi tomography in patients with suspected coronary artery disease . J Nucl Cardiol . 2004;11:527–533
  66. Valeti US , Miller TD , Hodge DO , et al.   Exercise single-photon emission computed tomography provides effective risk stratification of elderly men and elderly women . Circulation . 2005;111:1771–1776
  67. Patel GM , Hauser TH , Parker JA , et al.   Quantitative relationship of stress Tc-99m sestamibi lung uptake with resting Tl-201 lung uptake and with indices of left ventricular dysfunction and coronary artery disease . J Nucl Cardiol . 2004;11:408–413
  68. Romanens M , Gradel C , Saner H , et al.   Comparison of 99mTc-sestamibi lung/heart ratio, transient ischaemic dilation and perfusion defect size for the identification of severe and extensive coronary artery disease . Eur J Nucl Med . 2001;28:907–910
  69. Bacher-Stier C , Sharir T , Kavanagh PB , et al.   Postexercise lung uptake of 99mTc-sestamibi determined by a new automatic technique (validation and application in detection of severe and extensive coronary artery disease and reduced left ventricular function) . J Nucl Med . 2000;41:1190–1197
  70. Daou D , Delahaye N , Vilain D , et al.   Identification of extensive coronary artery disease (incremental value of exercise Tl-201 SPECT to clinical and stress test variables) . J Nucl Cardiol . 2002;9:161–168
  71. Abidov A , Bax JJ , Hayes SW , et al.   Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT . J Am Coll Cardiol . 2003;42:1818–1825
  72. Abidov A , Bax JJ , Hayes SW , et al.   Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD . J Nucl Med . 2004;45:1999–2007
  73. Daou D , Coaguila C , Delahaye N , et al.   Discordance between exercise SPECT lung Tl-201 uptake and left ventricular transient ischemic dilation in patients with CAD . J Nucl Cardiol . 2004;11:53–61
  74. Hansen CL , Cen P , Sanchez B , et al.   Comparison of pulmonary uptake with transient cavity dilation after dipyridamole Tl-201 perfusion imaging . J Nucl Cardiol . 2002;9:47–51
  75. Hansen CL , Sangrigoli R , Nkadi E , et al.   Comparison of pulmonary uptake with transient cavity dilation after exercise thallium-201 perfusion imaging . J Am Coll Cardiol . 1999;33:1323–1327
  76. Forster T , McNeill AJ , Salustri A , et al.   Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease . J Am Coll Cardiol . 1993;21:1591–1596
  77. Smart S , Wynsen J , Sagar K . Dobutamine-atropine stress echocardiography for reversible dysfunction during the first week after acute myocardial infarction (limitations and determinants of accuracy) . J Am Coll Cardiol . 1997;30:1669–1678
  78. Geleijnse ML , Vigna C , Kasprzak JD , et al.   Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study . Eur Heart J . 2000;21:1666–1673
  79. Gottdiener JS . Overview of stress echocardiography (uses, advantages, and limitations) . Prog Cardiovasc Dis . 2001;43:315–334
  80. Acampa W , Spinelli L , Petretta M , et al.   Prognostic value of myocardial ischemia in patients with uncomplicated acute myocardial infarction (direct comparison of stress echocardiography and myocardial perfusion imaging) . J Nucl Med . 2005;46:417–423
  81. Le Feuvre CL , Barthelemy O , Dubois-Laforgue D , et al.   Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes . Diabetes Metab . 2005;31:135–142
  82. Links JM , DePuey EG , Taillefer R , et al.   Attenuation correction and gating synergistically improve the diagnostic accuracy of myocardial perfusion SPECT . J Nucl Cardiol . 2002;9:183–187
  83. Heller GV , Bateman TM , Johnson LL , et al.   Clinical value of attenuation correction in stress-only Tc-99m sestamibi SPECT imaging . J Nucl Cardiol . 2004;11:273–281
  84. Hendel RC , Berman DS , Cullom SJ , et al.   Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging . Circulation . 1999;99:2742–2749
  85. Araujo LI , Jimenez-Hoyuela JM , McClellan JR , et al.   Improved uniformity in tomographic myocardial perfusion imaging with attenuation correction and enhanced acquisition and processing . J Nucl Med . 2000;41:1139–1144
  86. Kjaer A , Cortsen A , Rahbek B , et al.   Attenuation and scatter correction in myocardial SPET (improved diagnostic accuracy in patients with suspected coronary artery disease) . Eur J Nucl Med Mol Imaging . 2002;29:1438–1442
  87. Banzo I , Pena FJ , Allende RH , et al.   Prospective clinical comparison of non-corrected and attenuation- and scatter-corrected myocardial perfusion SPECT in patients with suspicion of coronary artery disease . Nucl Med Commun . 2003;24:995–1002
  88. Narayanan MV , King MA , Pretorius PH , et al.   Human-observer receiver-operating-characteristic evaluation of attenuation, scatter, and resolution compensation strategies for (99m)Tc myocardial perfusion imaging . J Nucl Med . 2003;44:1725–1734
  89. Grossman GB , Garcia EV , Bateman TM , et al.   Quantitative Tc-99m sestamibi attenuation-corrected SPECT (development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population) . J Nucl Cardiol . 2004;11:263–272
  90. Fricke E , Fricke H , Weise R , et al.   Attenuation correction of myocardial SPECT perfusion images with low-dose CT (evaluation of the method by comparison with perfusion PET) . J Nucl Med . 2005;46:736–744
  91. Utsunomiya D , Tomiguchi S , Shiraishi S , et al.   Initial experience with X-ray CT based attenuation correction in myocardial perfusion SPECT imaging using a combined SPECT/CT system . Ann Nucl Med . 2005;19:485–489
  92. Masood Y , Liu Y-H , DePuey EG , et al.   Clinical validation of attenuation correction using X-ray computed tomography-derived attenuation maps. Multicenter clinical trial with angiographic correlation . J Nucl Cardiol . 2005; (in press)
  93. Takahashi Y , Murase K , Higashino H , et al.   Attenuation correction of myocardial SPECT images with X-ray CT (effects of registration errors between X-ray CT and SPECT) . Ann Nucl Med . 2002;16:431–435
  94. Loghin C , Sdringola S , Gould KL . Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration (clinical significance, causes, and solutions) . J Nucl Med . 2004;45:1029–1039
  95. Go RT , Marwick TH , MacIntyre WJ , et al.   A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease . J Nucl Med . 1990;31:1899–1905
  96. MacIntyre WJ , Go RT , King JL , et al.   Clinical outcome of cardiac patients with negative thallium-201 SPECT and positive rubidium-82 PET myocardial perfusion imaging . J Nucl Med . 1993;34:400–404
  97. Marwick TH , Shan K , Patel S , et al.   Incremental value of rubidium-82 positron emission tomography for prognostic assessment of known or suspected coronary artery disease . Am J Cardiol . 1997;80:865–870
  98. Chow BJW , Wong JW , Yoshinaga K , et al.   Prognostic significance of dipyridamole-induced ST depression in patients with normal 82Rb PET myocardial perfusion imaging . J Nucl Med . 2005;46:1095–1101
  99. Chow BJ , Ananthasubramaniam K , deKemp RA , et al.   Comparison of treadmill exercise versus dipyridamole stress with myocardial perfusion imaging using rubidium-82 positron emission tomography . J Am Coll Cardiol . 2005;45:1227–1234
  100. Van Tosh A , Garza D , Roberti R , et al.   Serial myocardial perfusion imaging with dipyridamole and rubidium-82 to assess restenosis after angioplasty . J Nucl Med . 1995;36:1553–1560
  101. El Fakhri G , Sitek A , Guerin B , et al.   Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses . J Nucl Med . 2005;46:1264–1271
  102. Parkash R , deKemp RA , Ruddy TD , et al.   Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease . J Nucl Cardiol . 2004;11:440–449
  103. Lin JW , Sciacca RR , Chou RL , et al.   Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction . J Nucl Med . 2001;42:201–208
  104. American Heart Association . Heart Disease and Stroke Statistics—2005 Update . Dallas, TX: American Heart Association; 2005;
  105. Barbash GI , White HD , Modan M , et al.  Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial   Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy . J Am Coll Cardiol . 1993;22:707–713
  106. Kodama K , Sakagashira S , Hori M . Prognostic significance of diabetes mellitus in patients with acute myocardial infarction after recanalization . Diabetes Res Clin Pract . 1996;30:71–75
  107. Silva JA , Ramee SR , White CJ , et al.   Primary stenting in acute myocardial infarction (influence of diabetes mellitus in angiographic results and clinical outcome) . Am Heart J . 1999;138:446–455
  108. Granger CB , Califf RM , Young S , et al.  The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group   Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents . J Am Coll Cardiol . 1993;21:920–925
  109. Haffner SM , Lehto S , Ronnemaa T , et al.   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction . N Engl J Med . 1998;339:229–234
  110. Kang X , Berman DS , Lewin H , et al.   Comparative ability of myocardial perfusion sing-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus . Am Heart J . 1999;137:949–957
  111. Zarich SW , Cohen MC , Lane SE , et al.   Routine perioperative dipyridamole 201Tl imaging in diabetic patients undergoing vascular surgery . Diabetes Care . 1996;19:355–360
  112. De Lorenzo A , Lima RS , Siqueira-Filho AG , et al.   Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease . Am J Cardiol . 2002;90:827–832
  113. Wackers FJ , Young LH , Inzucchi SE , et al.   Detection of silent myocardial ischemia in asymptomatic diabetic subjects (the DIAD study) . Diabetes Care . 2004;27:1954–1961
  114. Araz M , Celen Z , Akdemir I , et al.   Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control . Acta Diabetol . 2004;41:38–43
  115. Zellweger MJ , Hachamovitch R , Kang X , et al.   Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients . Eur Heart J . 2004;25:543–550
  116. Yasuda I , Kawakami K , Shimada T , et al.   Systolic and diastolic left ventricular dysfunction in middle-aged asymptomatic non-insulin-dependent diabetics . J Cardiol . 1992;22:427–438
  117. Takahashi N , Iwasaka T , Sugiura T , et al.   Diastolic time in diabetes. Impairment of diastolic time during dynamic exercise in type 2 diabetes with retinopathy . Chest . 1991;100:748–753
  118. Arora GD , Reeves WC , Movahed A . Alteration of coronary perfusion reserve in hypertensive patients with diabetes . J Hum Hypertens . 1994;8:51–57
  119. Sarnak MJ , Levey AS , Schoolwerth AC , et al.   Kidney disease as a risk factor for development of cardiovascular disease (a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention) . Circulation . 2003;108:2154–2169
  120. Dahan M , Viron BM , Faraggi M , et al.   Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients . Kidney Int . 1998;54:255–262
  121. Patel AD , Abo-Auda WS , Davis JM , et al.   Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation . Am J Cardiol . 2003;92:146–151
  122. Feola M , Biggi A , Ribichini F , et al.   Predicting cardiac events with Tl201 dipyridamole myocardial scintigraphy in renal transplant recipients . J Nephrol . 2002;15:48–53
  123. De Lima JJ , Sabbaga E , Vieira ML , et al.   Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing . Hypertension . 2003;42:263–268
  124. Dussol B , Bonnet JL , Sampol J , et al.   Prognostic value of inducible myocardial ischemia in predicting cardiovascular events after renal transplantation . Kidney Int . 2004;66:1633–1639
  125. Hase H , Joki N , Ishikawa H , et al.   Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease . Nephrol Dial Transplant . 2004;19:1161–1167
  126. Yao SS , Qureshi E , Nichols K , et al.   Prospective validation of a quantitative method for differentiating ischemic versus nonischemic cardiomyopathy by technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography . Clin Cardiol . 2004;27:615–620
  127. Danias PG , Papaioannou GI , Ahlberg AW , et al.   Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy . Am J Cardiol . 2004;94:14–19
  128. Sciagra R , Giaccardi M , Porciani MC , et al.   Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy . J Nucl Med . 2004;45:164–168
  129. Vaccarino V , Parsons L , Every NR , et al.  The National Registry of Myocardial Infarction P   Sex-based differences in early mortality after myocardial infarction . N Engl J Med . 1999;341:217–225
  130. Mieres JH , Shaw LJ , Hendel RC . Consensus statement from the American Society of Nuclear Cardiology Task Force on Women and Heart Disease. The role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women . J Nucl Cardiol . 2003;10:95–101
  131. Santana-Boado C , Candell-Riera J , Castell C . Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men . J Nucl Med . 1998;39:751–755
  132. Friedman TD , Greene AC , Iskandrain AS . Exercise thallium-201 myocardial perfusion scintigraphy in women (correlation with coronary arteriography) . Am J Cardiol . 1982;49:1632–1637
  133. Amanullah AM , Berman DS , Hachamovitch R . Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT . Am J Cardiol . 1997;80:132–137
  134. Hachamovitch R , Berman DS , Kiat H . Effective risk stratification using exercise myocardial perfusion SPECT in women (gender-related differences in prognostic nuclear testing) . J Am Coll Cardiol . 1996;28:34–44
  135. Goodgold HM , Rehder JG , Samuels LD , et al.   Improved interpretation of exercise Tl-201 myocardial perfusion scintigraphy in women (characterization of breast attenuation artifacts) . Radiology . 1987;165:361–366
  136. Hansen CL , Crabbe D , Rubin S . Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women (an effect of smaller chamber) . J Am Coll Cardiol . 1996;67:69–77
  137. Taillefer R , DePuey EG , Udelson JE . Diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG gated SPECT) in detecting coronary artery disease in women . J Am Coll Cardiol . 1997;29:69–77
  138. Akinboboye OO , Idris O , Onwuanyi A , et al.   Incidence of major cardiovascular events in black patients with normal myocardial stress perfusion study results . J Nucl Cardiol . 2001;8:541–547
  139. Shaw LJ , Hendel RC , Cerquiera M , et al.   Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging . J Am Coll Cardiol . 2005;45:1494–1504
  140. Lowry PJ , Glover DR , Mace PJ , et al.   Coronary artery disease in Asians in Birmingham . Br Heart J . 1984;52:610–613
  141. Liew CF , Seah ES , Yeo KP , et al.   Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects . Int J Obes Relat Metab Disord . 2003;27:784–789
  142. Hughes LO , Raval U , Raftery EB . First myocardial infarctions in Asian and white men . Br Med J . 1989;298:1345–1350
  143. Galasko GI , Senior R , Lahiri A . Ethnic differences in the prevalence and aetiology of left ventricular systolic dysfunction in the community (the Harrow heart failure watch) . Heart . 2005;91:595–600
  144. Dhawan J , Bray CL , Warburton R , et al.   Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians. Genetic or environmental effect? . Br Heart J . 1994;72:413–421
  145. Saha N , Tong MC , Tay JS , et al.   DNA polymorphisms of the apolipoprotein B gene in Chinese coronary artery disease patients . Clin Genet . 1992;42:164–170
  146. Hammermeister KE , DeRouen TA , Dodge HT . Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations . Circulation . 1979;59:421–430
  147. Multicenter Postinfarction Research Group . Risk stratification and survival after myocardial infarction . N Engl J Med . 1983;309:331–367
  148. Zaret BL , Wackers FJ , Terrin ML , et al.   Value of radionuclide rest and exercise left ventricular ejection fraction to access survival of patients following thrombolytic therapy for acute myocardial infarction (results of the Thrombolysis in Myocardial Infarction (TIMI) phase II study) . J Am Coll Cardiol . 1995;26:73–79
  149. Kober L , Torp-Pedersen C , Pedersen OD , et al.   Importance of congestive heart failure and interaction of congestive heart failure and left ventricular systolic function on prognosis in patients with acute myocardial infarction . Am J Cardiol . 1996;78:1124–1128
  150. O’Connor CM , Hathaway WR , Bates ER , et al.   Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction (development of a predictive model) . Am Heart J . 1997;133:663–673
  151. Yang KT , Chen HD . A semi-automated method for edge detection in the evaluation of left ventricular function using ECG-gated single-photon emission tomography . Eur J Nucl Med . 1994;21:1206–1211
  152. Najm YC , Timmis AD , Maisey MN , et al.   The evaluation of ventricular function using gated myocardial imaging with Tc-99m MIBI . Eur Heart J . 1989;10:142–148
  153. DePuey EG , Nichols K , Dobrinsky C . Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT . J Nucl Med . 1993;34:1871–1876
  154. Boonyaprapa S , Ekmahachai M , Thanachaikun N , et al.   Measurement of left ventricular ejection fraction from gated technetium-99m sestamibi myocardial images . Eur J Nucl Med . 1995;22:528–531
  155. Germano G , Kiat H , Kavanagh PB , et al.   Automatic quantification of ejection fraction from gated myocardial perfusion SPECT . J Nucl Med . 1995;36:2138–2147
  156. Everaert H , Franken PR , Flamen P , et al.   Left ventricular ejection fraction from gated SPET myocardial perfusion studies (a method based on the radial distribution of count rate density across the myocardial wall) . Eur J Nucl Med . 1996;23:1628–1633
  157. Smith WH , Kastner RJ , Calnon DA , et al.   Quantitative gated single photon emission computed tomography imaging (a counts-based method for display and measurement of regional and global ventricular systolic function) . J Nucl Cardiol . 1997;4:451–463
  158. Brigger P , Bacharach SL , Srinivasan G , et al.   Segmentation of gated Tl-SPECT images and computation of ejection fraction (a different approach) . J Nucl Cardiol . 1999;6:286–297
  159. Liu YH , Sinusas AJ , Khaimov D , et al.   New hybrid count- and geometry-based method for quantification of left ventricular volumes and ejection fraction from ECG-gated SPECT (methodology and validation) . J Nucl Cardiol . 2005;12:55–65
  160. Itti E , Rosso J , Hammami H , et al.   Myocardial tracking, a new method to calculate ejection fraction with gated SPECT (validation with 201Tl versus planar angiography) . J Nucl Med . 2001;42:845–852
  161. He ZX , Cwajg E , Preslar JS , et al.   Accuracy of left ventricular ejection fraction determined by gated myocardial perfusion SPECT with Tl-201 and Tc-99m sestamibi (comparison with first-pass radionuclide angiography) . J Nucl Cardiol . 1999;6:412–417
  162. Williams KA , Taillon LA . Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images. Comparison with assessment by contrast ventriculography and first-pass radionuclide angiography . J Am Coll Cardiol . 1996;27:173–181
  163. Calnon DA , Kastner RJ , Smith WH , et al.   Validation of a new counts-based gated single photon emission computed tomography method for quantifying left ventricular systolic function (comparison with equilibrium radionuclide angiography) . J Nucl Cardiol . 1997;4:464–471
  164. Chua T , Kiat H , Germano G , et al.   Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy . J Am Coll Cardiol . 1994;23:1107–1114
  165. Vaduganathan P , He ZX , Vick GW , et al.   Evaluation of left ventricular wall motion, volumes, and ejection fraction by gated myocardial tomography with technetium 99m-labeled tetrofosmin (a comparison with cine magnetic resonance imaging) . J Nucl Cardiol . 1999;6:3–10
  166. Vallejo E , Dione DP , Sinusas AJ , et al.   Assessment of left ventricular ejection fraction with quantitative gated SPECT (accuracy and correlation with first-pass radionuclide angiography) . J Nucl Cardiol . 2000;7:461–470
  167. Navare SM , Wackers FJ , Liu YH . Comparison of 16-frame and 8-frame gated SPET imaging for determination of left ventricular volumes and ejection fraction . Eur J Nucl Med Mol Imaging . 2003;30:1330–1337
  168. Vallejo E , Dione DP , Bruni WL , et al.   Reproducibility and accuracy of gated SPECT for determination of left ventricular volumes and ejection fraction (experimental validation using MRI) . J Nucl Med . 2000;41:874–882 discussion 883-6
  169. Manrique A , Faraggi M , Vera P , et al.   201Tl and 99mTc-MIBI gated SPECT in patients with large perfusion defects and left ventricular dysfunction (comparison with equilibrium radionuclide angiography) . J Nucl Med . 1999;40:805–809
  170. DePuey EG , Parmett S , Ghesani M , et al.   Comparison of Tc-99m sestamibi and Tl-201 gated perfusion SPECT . J Nucl Cardiol . 1999;6:278–285
  171. Smanio PE , Watson DD , Segalla DL , et al.   Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging . J Am Coll Cardiol . 1997;30:1687–1692
  172. Links JM , DePuey EG , Taillefer R , et al.   Attenuation correction and gating synergistically improve the diagnostic accuracy of myocardial perfusion SPECT . J Nucl Cardiol . 2002;9:183–187
  173. Johnson LL , Verdesca SA , Aude WY , et al.   Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms . J Am Coll Cardiol . 1997;30:1641–1648
  174. Sakamoto K , Nakamura T , Zen K , et al.   Identification of exercise-induced left ventricular systolic and diastolic dysfunction using gated SPECT in patients with coronary artery disease . J Nucl Cardiol . 2004;11:152–158
  175. Liao L , Smith WT , Tuttle RH , et al.   Prediction of death and nonfatal myocardial infarction in high-risk patients (a comparison between the Duke treadmill score, peak exercise radionuclide angiography, and SPECT perfusion imaging) . J Nucl Med . 2005;46:5–11
  176. Van Kriekinge SD , Berman DS , Germano G . Automatic quantification of left ventricular ejection fraction from gated blood pool SPECT . J Nucl Cardiol . 1999;6:498–506
  177. Kim SJ , Kim IJ , Kim YS , et al.   Gated blood pool SPECT for measurement of left ventricular volumes and left ventricular ejection fraction (comparison of 8 and 16 frame gated blood pool SPECT) . Int J Cardiovasc Imaging . 2005;21:261–266
  178. Higuchi T , Taki J , Nakajima K , et al.   Left ventricular ejection and filling rate measurement based on the automatic edge detection method of ECG-gated blood pool single-photon emission tomography . Ann Nucl Med . 2004;18:507–511
  179. Nichols K , Humayun N , De Bondt P , et al.   Model dependence of gated blood pool SPECT ventricular function measurements . J Nucl Cardiol . 2004;11:282–292
  180. Vanhove C , Franken PR , Defrise M , et al.   Comparison of 180 degrees and 360 degrees data acquisition for determination of left ventricular function from gated myocardial perfusion tomography and gated blood pool tomography . Eur J Nucl Med Mol Imaging . 2003;30:1498–1504
  181. Akinboboye O , Nichols K , Yang Y , et al.   Accuracy of radionuclide ventriculography assessed by magnetic resonance imaging in patients with abnormal left ventricles . J Nucl Cardiol . 2005;12:418–427
  182. de Groote P , Millaire A , Foucher-Hossein C , et al.   Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure . J Am Coll Cardiol . 1998;32:948–954
  183. Di Salvo TG , Mathier M , Semigran MJ , et al.   Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure . J Am Coll Cardiol . 1995;25:1143–1153
  184. Daou D , Van Kriekinge SD , Coaguila C , et al.   Automatic quantification of right ventricular function with gated blood pool SPECT . J Nucl Cardiol . 2004;11:293–304
  185. Kim SJ , Kim IJ , Kim YS , et al.   Automatic quantification of right ventricular volumes and right ventricular ejection fraction with gated blood pool SPECT (comparison of 8- and 16-frame gated blood pool SPECT with first-pass radionuclide angiography) . J Nucl Cardiol . 2005;12:553–559
  186. Groch MW , Marshall RC , Erwin WD , et al.   Quantitative gated blood pool SPECT for the assessment of coronary artery disease at rest . J Nucl Cardiol . 1998;5:567–573
  187. Groch MW , Schippers DJ , Marshall RC , et al.   Quantitative gated blood pool SPECT (analysis of 3-dimensional models for the assessment of regional myocardial wall motion) . J Nucl Cardiol . 2002;9:271–284
  188. Casset-Senon D , Philippe L , Babuty D , et al.   Diagnosis of arrhythmogenic right ventricular cardiomyopathy by Fourier analysis of gated blood pool single-photon emission tomography . Am J Cardiol . 1998;82:1399–1404
  189. Chevalier P , Bontemps L , Fatemi M , et al.   Gated blood-pool SPECT evaluation of changes after radiofrequency catheter ablation of accessory pathways (evidence for persistent ventricular preexcitation despite successful therapy) . J Am Coll Cardiol . 1999;34:1839–1846
  190. Fauchier L , Marie O , Casset-Senon D , et al.   Ventricular dyssynchrony and risk markers of ventricular arrhythmias in nonischemic dilated cardiomyopathy (a study with phase analysis of angioscintigraphy) . Pacing Clin Electrophysiol . 2003;26:352–356
  191. Adachi I , Akagi H , Umeda T , et al.   Gated blood pool SPECT improves reproducibility of right and left ventricular Fourier phase analysis in radionuclide angiography . Ann Nucl Med . 2003;17:711–716
  192. Kasama S , Toyama T , Hoshizaki H , et al.   Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy . Chest . 2002;122:542–548
  193. Pigott JD , Kouchoukos NT , Oberman A , et al.   Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function . J Am Coll Cardiol . 1985;5:1036–1045
  194. Marwick TH . The viable myocardium (epidemiology, detection, and clinical implications) . Lancet . 1998;351:815–819
  195. Acampa W , Petretta M , Spinelli L , et al.   Survival benefit after revascularization is independent of left ventricular ejection fraction improvement in patients with previous myocardial infarction and viable myocardium . Eur J Nucl Med Mol Imaging . 2005;32:430–437
  196. Meluzin J , Cerny J , Spinarova L , et al.   Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability . Eur J Heart Fail . 2003;5:85–93
  197. Bonow RO , Dilsizian V . Thallium 201 for assessment of myocardial viability . Semin Nucl Med . 1991;21:230–241
  198. Schinkel AF , Bax JJ , Sozzi FB , et al.   Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction . Heart . 2002;88:125–130
  199. Tillisch J , Brunken R , Marshall R , et al.   Reversibility of cardiac wall-motion abnormalities predicted by positron tomography . N Engl J Med . 1986;314:884–888
  200. Marwick TH , MacIntyre WJ , Lafont A , et al.   Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism . Circulation . 1992;85:1347–1353
  201. Gerber BL , Vanoverschelde JL , Bol A , et al.   Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation . Circulation . 1996;94:651–659
  202. Tamaki N , Yonekura Y , Yamashita K , et al.   Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting . Am J Cardiol . 1989;64:860–865
  203. Gropler RJ , Geltman EM , Sampathkumaran K , et al.   Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography . J Am Coll Cardiol . 1993;22:1587–1597
  204. Maes AF , Borgers M , Flameng W , et al.   Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up . J Am Coll Cardiol . 1997;29:62–68
  205. Tamaki N , Kawamoto M , Tadamura E , et al.   Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography . Circulation . 1995;91:1697–1705
  206. Knuuti MJ , Saraste M , Nuutila P , et al.   Myocardial viability (fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization) . Am Heart J . 1994;127:785–796
  207. Baer FM , Voth E , Deutsch HJ , et al.   Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization . J Am Coll Cardiol . 1996;28:60–69
  208. Lucignani G , Paolini G , Landoni C , et al.   Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease . Eur J Nucl Med . 1992;19:874–881
  209. Carrel T , Jenni R , Haubold-Reuter S , et al.   Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction . Eur J Cardiothorac Surg . 1992;6:479–484
  210. Bax JJ , Wijns W , Cornel JH , et al.   Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease (comparison of pooled data) . J Am Coll Cardiol . 1997;30:1451–1460
  211. Di Carli MF , Davidson M , Little R , et al.   Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction . Am J Cardiol . 1994;73:527–533
  212. Lee KS , Marwick TH , Cook SA , et al.   Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization . Circulation . 1994;90:2687–2694
  213. vom Dahl J , Altehoefer C , Sheehan FH , et al.   Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease . J Nucl Med . 1997;38:742–748
  214. Bax JJ , Patton JA , Poldermans D , et al.   18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography (cardiac applications) . Semin Nucl Med . 2000;30:281–298
  215. Di Carli MF , Asgarzadie F , Schelbert HR , et al.   Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy . Circulation . 1995;92:3436–3444
  216. Eitzman D , al-Aouar Z , Kanter HL , et al.   Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography . J Am Coll Cardiol . 1992;20:559–565
  217. Samady H , Elefteriades JA , Abbott BG , et al.   Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome . Circulation . 1999;100:1298–1304
  218. Sandler MP , Bax JJ , Patton JA , et al.   Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera . J Nucl Med . 1998;39:2035–2043
  219. Sandler MP , Patton JA . Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography (an alternative for determining myocardial viability) . J Nucl Cardiol . 1996;3:342–349
  220. Huitink JM , Visser FC , Bax JJ , et al.   Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction . Am J Cardiol . 1998;81:1072–1077
  221. Huitink JM , Visser FC , van Lingen A , et al.   Feasibility of planar fluorine-18-FDG imaging after recent myocardial infarction to assess myocardial viability . J Nucl Med . 1995;36:975–981
  222. Kalff V , Berlangieri SU , Van Every B , et al.   Is planar thallium-201/fluorine-18 fluorodeoxyglucose imaging a reasonable clinical alternative to positron emission tomographic myocardial viability scanning? . Eur J Nucl Med . 1995;22:625–632
  223. Burt RW , Perkins OW , Oppenheim BE , et al.   Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability . J Nucl Med . 1995;36:176–179
  224. Martin WH , Delbeke D , Patton JA , et al.   FDG-SPECT (correlation with FDG-PET) . J Nucl Med . 1995;36:988–995
  225. Bax JJ , Cornel JH , Visser FC , et al.   Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization . J Nucl Med . 1998;39:1481–1486
  226. Chen EQ , MacIntyre WJ , Go RT , et al.   Myocardial viability studies using fluorine-18-FDG SPECT (a comparison with fluorine-18-FDG PET) . J Nucl Med . 1997;38:582–586
  227. Srinivasan G , Kitsiou A , Bacharach S , et al.   [18F]Fluorodeoxyglucose single photon emission computed tomography. Can it replace PET and thallium SPECT for the assessment of myocardial viability? . Circulation . 1998;97:843–850
  228. Bax J , Cornel J , Visser F , et al.   Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography . J Am Coll Cardiol . 1997;30:377–383
  229. Bax JJ , Cornel JH , Visser FC , et al.   F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization . J Nucl Cardiol . 1997;4:302–308
  230. Bonow RO , Dilsizian V , Cuocolo A , et al.   Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose . Circulation . 1991;83:26–37
  231. Dilsizian V , Perrone-Filardi P , Arrighi JA , et al.   Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography . Circulation . 1993;88:941–952
  232. Altehoefer C , vom Dahl J , Buell U , et al.   Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease . Eur J Nucl Med . 1994;21:37–45
  233. Maddahi J , Schelbert H , Brunken R , et al.   Role of thallium-201 and PET imaging in evaluation of myocardial viability and management of patients with coronary artery disease and left ventricular dysfunction . J Nucl Med . 1994;35:707–715
  234. Tamaki N , Kawamoto M , Takahashi N , et al.   Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction (comparison with stress thallium imaging) . J Am Coll Cardiol . 1993;22:1621–1627
  235. Backus M , Piwnica-Worms D , Hockett D , et al.   Microprobe analysis of Tc-MIBI in heart cells (calculation of mitochondrial membrane potential) . Am J Physiol . 1993;265:C178–C187
  236. Piwnica-Worms D , Kronauge JF , Chiu ML . Enhancement by tetraphenylborate of technetium-99m-MIBI uptake kinetics and accumulation in cultured chick myocardial cells . J Nucl Med . 1991;32:1992–1999
  237. Piwnica-Worms D , Kronauge JF , Chiu ML . Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence . Circulation . 1990;82:1826–1838
  238. Li QS , Frank TL , Franceschi D , et al.   Technetium-99m methoxyisobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs . J Nucl Med . 1988;29:1539–1548
  239. Franceschi M , Guimond J , Zimmerman RE , et al.   Myocardial clearance of Tc-99m hexakis-2-methoxy-2-methylpropyl isonitrile (MIBI) in patients with coronary artery disease . Clin Nucl Med . 1990;15:307–312
  240. Li QS , Solot G , Frank TL , et al.   Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI) . J Nucl Med . 1990;31:1069–1076
  241. Sinusas A , Bergin J , Edwards N , et al.   Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis . Circulation . 1994;89:2332–2341
  242. Senior R , Kaul S , Raval U , et al.   Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy . J Nucl Cardiol . 2002;9:454–462
  243. Batista JF , Pereztol O , Valdes JA , et al.   Improved detection of myocardial perfusion reversibility by rest-nitroglycerin Tc-99m-MIBI (comparison with TI-201 reinjection) . J Nucl Cardiol . 1999;6:480–486
  244. Greco C , Ciavolella M , Tanzilli G , et al.   Preoperative identification of viable myocardium (effectiveness of nitroglycerine-induced changes in myocardial Sestamibi uptake) . Cardiovasc Surg . 1998;6:149–155
  245. Greco C , Tanzilli G , Ciavolella M , et al.   Nitroglycerin-induced changes in myocardial sestamibi uptake to detect tissue viability (radionuclide comparison before and after revascularization) . Coron Artery Dis . 1996;7:877–884
  246. Kostkiewicz M , Olszowska M , Przewlocki T , et al.   Prognostic value of nitrate enhanced Tc99m MIBI SPECT study in detecting viable myocardium in patients with coronary artery disease . Int J Cardiovasc Imaging . 2003;19:129–135
  247. Tzonevska A , Tzvetkov K , Dimitrova M , et al.   Assessment of myocardial viability with (99m)Tc-sestamibi-gated SPET images in patients undergoing percutaneous transluminar coronary angioplasty . Hell J Nucl Med . 2005;8:48–53
  248. Duncan BH , Ahlberg AW , Levine MG , et al.   Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability . Am J Cardiol . 2000;85:680–684
  249. Kauffman GJ , Boyne TS , Watson DD . Comparison of rest Tl201 imaging and rest tc99m-sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction . J Am Coll Cardiol . 1996;27:1592–1597
  250. Dilsizian V , Arrighi JA , Diodati JG , et al.   Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose . Circulation . 1994;89:578–587
  251. Soufer R , Dey HM , Ng CK , et al.   Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability . Am J Cardiol . 1995;75:1214–1219
  252. Sawada SG , Allman KC , Muzik O , et al.   Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects . J Am Coll Cardiol . 1994;23:92–98
  253. Young LH , Li J , Baron SJ , et al.   AMP-activated protein kinase (a key stress signaling pathway in the heart) . Trends Cardiovasc Med . 2005;15:110–118
  254. He ZX , Shi RF , Wu YJ , et al.   Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease . Circulation . 2003;108:1208–1213
  255. Southworth R , Dearling JL , Medina RA , et al.   Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart (application of a new autoradiographic technique) . Eur J Nucl Med Mol Imaging . 2002;29:1334–1341
  256. McNulty PH , Jagasia D , Cline GW , et al.   Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited-duration coronary occlusion . Circulation . 2000;101:917–922
  257. Yamamichi Y , Kusuoka H , Morishita K , et al.   Metabolism of iodine-123-BMIPP in perfused rat hearts . J Nucl Med . 1995;36:1043–1050
  258. Nohara R , Hosokawa R , Hirai T , et al.   Basic kinetics of 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (BMIPP) in canine myocardium . Int J Cardiac Imag . 1999;15:11–20
  259. Nishimura T , Nagata S , Uehara T , et al.   Prognosis of hypertrophic cardiomyopathy (assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography) . Ann Nucl Med . 1996;10:71–78
  260. Matsuo S , Nakamura Y , Takahashi M , et al.   Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia . Jpn Circ J . 1998;62:167–172
  261. Tadamura E , Kudoh T , Hattori N , et al.   Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy . J Nucl Med . 1998;39:390–396
  262. Yazaki Y , Isobe M , Takahashi W , et al.   Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT (correlation with clinicopathological findings and clinical course) . Heart . 1999;81:153–159
  263. Kitagawa K , Takeda K , Saito K , et al.   Differences in fatty acid metabolic disorder between ischemic myocardium and doxorubicin-induced myocardial damage (assessment using BMIPP dynamic SPECT with analysis by the Rutland method) . J Nucl Med . 2002;43:1286–1294
  264. Ito T , Hoshida S , Nishino M , et al.   Relationship between evaluation by quantitative fatty acid myocardial scintigraphy and response to beta-blockade therapy in patients with dilated cardiomyopathy . Eur J Nucl Med . 2001;28:1811–1816
  265. Yoshinaga K , Tahara M , Torii H , et al.   Predicting the effects on patients with dilated cardiomyopathy of beta-blocker therapy, by using iodine-123 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (BMIPP) myocardial scintigraphy . Ann Nucl Med . 1998;12:341–347
  266. Fujibayashi Y , Yonekura Y , Takemura Y , et al.   Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R, S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration . J Nucl Med . 1990;31:1818–1822
  267. Nishimura M , Hashimoto T , Kobayashi H , et al.   Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients . Kidney Int . 2004;66:811–819
  268. Hosokawa R , Nohara R , Fujibayashi Y , et al.   Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion (implications for clinical SPECT) . J Nucl Med . 1997;38:1857–1863
  269. Dilsizian V , Bateman TM , Bergmann SR , et al.   Metabolic imaging with b-methyl-p-[123I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia . Circulation . 2005;112:2169–2174
  270. Chikamori T , Fujita H , Nanasato M , et al.   Prognostic value of I-123 15-(p-iodophenyl)-3-(R, S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease . J Nucl Cardiol . 2005;12:172–178
  271. Chaitman BR , Skettino SL , Parker JO , et al.   Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina . J Am Coll Cardiol . 2004;43:1375–1382
  272. Chaitman BR , Pepine CJ , Parker JO , et al.   Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina (a randomized controlled trial) . JAMA . 2004;291:309–316
  273. Fukuda H , Syrota A , Charbonneau P , et al.   Use of 11C-triphenylmethylphosphonium for the evaluation of membrane potential in the heart by positron-emission tomography . Eur J Nucl Med . 1986;11:478–483
  274. Dence CS , Herrero P , Schwarz SW , et al.   Imaging myocardium enzymatic pathways with carbon-11 radiotracers . Methods Enzymol . 2004;385:286–315
  275. Peterson LR , Herrero P , Schechtman KB , et al.   Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women . Circulation . 2004;109:2191–2196
  276. Razeghi P , Young ME , Alcorn JL , et al.   Metabolic gene expression in fetal and failing human heart . Circulation . 2001;104:2923–2931
  277. Depré C , Shipley GL , Chen W , et al.   Unloaded heart. in vivo replicates fetal gene expression of cardiac hypertrophy . Nat Med . 1998;4:1269–1275
  278. Davila-Roman VG , Vedala G , Herrero P , et al.   Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy . J Am Coll Cardiol . 2002;40:271–277
  279. Ataka K , Chen D , Levitsky S , et al.   Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion . Circulation . 1992;86: II371-6
  280. Lesnefsky EJ , Gallo DS , Ye J , et al.   Aging increases ischemia-reperfusion injury in the isolated, buffer-perfused heart . J Lab Clin Med . 1994;124:843–851
  281. Misare BD , Krukenkamp IB , Levitsky S . Age-dependent sensitivity to unprotected cardiac ischemia (the senescent myocardium) . J Thorac Cardiovasc Surg . 1992;103:60–64
  282. Centers for Disease Control . Mortality from coronary heart disease and acute myocardial infarction—United States, 1998 . Morbid Mort Weekly Rep . 2001;50:90–93
  283. Abu-Errish G , Neely JR , Whitmer J , et al.   Fatty acid oxidation by isolated perfused working hearts of aged rats . Am J Physiol . 1977;232:E258–E262
  284. McMillin JB , Taffet G , Taegtmeyer H , et al.   Mitochondrial metabolism and substrate competition in the aging Fischer rat heart . Cardiovasc Res . 1993;27:2222–2228
  285. Escriva F , Agote M , Rubio E , et al.   In vivo insulin-dependent glucose uptake of specific tissues is decreased during aging of mature Wistar rats . Endocrinology . 1997;138:49–54
  286. Kates AM , Herrero P , Dence C , et al.   Impact of aging on substrate metabolism by the human heart . J Am Coll Cardiol . 2003;41:293–299
  287. Soto PF , Herrero P , Kates AM , et al.   Impact of aging on myocardial metabolic response to dobutamine . Am J Physiol . 2003;285:H2158–H2164
  288. Merlet P , Dubois-Rande JL , Adnot S , et al.   Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy . J Cardiovasc Pharmacol . 1992;19:10–16
  289. Rabinovitch MA , Rose CP , Rouleau JL , et al.   Metaiodobenzylguanidine [131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure . Circ Res . 1987;61:797–804
  290. Simmons WW , Freeman MR , Grima EA , et al.   Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy . Circulation . 1994;89:2843–2851
  291. Imamura Y , Ando H , Mitsuoka W , et al.   Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause . J Am Coll Cardiol . 1995;26:1594–1599
  292. Wakasugi S , Wada A , Hasegawa Y , et al.   Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine . J Nucl Med . 1992;33:208–214
  293. Takeishi Y , Sukekawa H , Sakurai T , et al.   Noninvasive identification of anthracycline cardiotoxicity (comparison of 123I-MIBG and 123I-BMIPP imaging) . Ann Nucl Med . 1994;8:177–182
  294. Valdes Olmos RA , ten Bokkel Huinink WW , ten Hoeve RF , et al.   Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy . Eur J Cancer . 1995;31A:26–31
  295. Merlet P , Valette H , Dubois-Rande JL , et al.   Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure . J Nucl Med . 1992;33:471–477
  296. Nakata T , Miyamoto K , Doi A , et al.   Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts . J Nucl Cardiol . 1998;5:579–590
  297. Ogita H , Shimonagata T , Fukunami M , et al.   Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure (a prospective study) . Heart . 2001;86:656–660
  298. Wakabayashi T , Nakata T , Hashimoto A , et al.   Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death . J Nucl Med . 2001;42:1757–1767
  299. Gerson MC , McGuire N , Wagoner LE . Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy . J Card Fail . 2003;9:384–391
  300. Somsen GA , van Vlies B , de Milliano PA , et al.   Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure . Heart . 1996;76:218–222
  301. Takeishi Y , Atsumi H , Fujiwara S , et al.   ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure . J Nucl Med . 1997;38:1085–1089
  302. Suwa M , Otake Y , Moriguchi A , et al.   Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy . Am Heart J . 1997;133:353–358
  303. Kakuchi H , Sasaki T , Ishida Y , et al.   Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment . Heart . 1999;81:148–152
  304. Agostini D , Belin A , Amar MH , et al.   Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy (a 123I-MIBG scintigraphic study) . J Nucl Med . 2000;41:845–851
  305. Lotze U , Kaepplinger S , Kober A , et al.   Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy (assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake) . J Nucl Med . 2001;42:49–54
  306. Matsui T , Tsutamoto T , Maeda K , et al.   Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments—comparison with neurohumoral factors . Circ J . 2002;66:537–543
  307. Glowniak JV , Turner FE , Gray LL , et al.   Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants . J Nucl Med . 1989;30:1182–1191
  308. De Marco T , Dae M , Yuen-Green MS , et al.   Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart (evidence for late reinnervation) . J Am Coll Cardiol . 1995;25:927–931
  309. Guertner C , Krause BJ , Klepzig H , et al.   Sympathetic re-innervation after heart transplantation (dual-isotope neurotransmitter scintigraphy, norepinephrine content and histological examination) . Eur J Nucl Med . 1995;22:443–452
  310. Estorch M , Camprecios M , Flotats A , et al.   Sympathetic reinnervation of cardiac allografts evaluated by 123I-MIBG imaging . J Nucl Med . 1999;40:911–916
  311. Toba M , Ishida Y , Fukuchi K , et al.   Sympathetic reinnervation demonstrated on serial iodine-123-metaiodobenzylguanidine SPECT images after cardiac transplantation . J Nucl Med . 1998;39:1862–1864
  312. Lovric SS , Avbelj V , Trobec R , et al.   Sympathetic reinnervation after heart transplantation, assessed by iodine-123 metaiodobenzylguanidine imaging, and heart rate variability . Eur J Cardiothorac Surg . 2004;26:736–741
  313. Turpeinen AK , Vanninen E , Kuikka JT , et al.   Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM . Diabetes Care . 1996;19:1083–1090
  314. Schnell O , Muhr D , Weiss M , et al.   Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients . Diabetes . 1996;45:801–805
  315. Schnell O , Kirsch CM , Stemplinger J , et al.   Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy . Diabetologia . 1995;38:1345–1352
  316. Schnell O , Muhr D , Dresel S , et al.   Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type 1) diabetes mellitus at one-year follow-up . Diabet Med . 1997;14:57–62
  317. Utsunomiya K , Narabayashi I , Tamura K , et al.   Effects of aldose reductase inhibitor and vitamin B12 on myocardial uptake of iodine-123 metaiodobenzylguanidine in patients with non-insulin-dependent diabetes mellitus . Eur J Nucl Med . 1998;25:1643–1648
  318. Utsunomiya K , Narabayashi I , Nakatani Y , et al.   I-123 MIBG cardiac imaging in diabetic neuropathy before and after epalrestat therapy . Clin Nucl Med . 1999;24:418–420
  319. Kreiner G , Wolzt M , Fasching P , et al.   Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function . Diabetes . 1995;44:543–549
  320. Scognamiglio R , Avogaro A , Casara D , et al.   Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus . J Am Coll Cardiol . 1998;31:404–412
  321. Ohno T , Toyama T , Hoshizaki H , et al.   Evaluation of cardiac sympathetic nervous function by 123I-metaiodobenzylguanidine scintigraphy in insulin-treated non-insulin dependent diabetics with hypoglycemia unawareness . Intern Med . 1996;35:94–99
  322. The Diabetes Control and Complications Trial Research Group . Hypoglycemia in the Diabetes Control and Complications Trial . Diabetes . 1997;46:271–286
  323. Nishimura Y , Fukuchi K , Katafuchi T , et al.   Superimposed display of coronary artery on gated myocardial perfusion scintigraphy . J Nucl Med . 2004;45:1444–1449
  324. Blankenberg FG , Strauss HW . Nuclear medicine applications in molecular imaging . J Magn Reson Imaging . 2002;16:352–361
  325. Sadeghi MM , Krassilnikova S , Zhang J , et al.   Detection of injury-induced vascular remodeling by targeting activated avb3 integrin in vivo . Circulation . 2004;110:84–90
  326. Dobrucki LW , Sinusas AJ . Molecular cardiovascular imaging . Curr Cardiol Rep . 2005;7:130–135
  327. Surti S , Karp JS , Perkins AE , et al.   Imaging performance of A-PET (a small animal PET camera) . IEEE Trans Med Imaging . 2005;24:844–852
  328. Schafers KP , Reader AJ , Kriens M , et al.   Performance evaluation of the 32-module quadHIDAC small-animal PET scanner . J Nucl Med . 2005;46:996–1004
  329. Tai YC , Ruangma A , Rowland D , et al.   Performance evaluation of the microPET focus (a third-generation microPET scanner dedicated to animal imaging) . J Nucl Med . 2005;46:455–463
  330. Stegger L , Schafers KP , Flogel U , et al.   Monitoring left ventricular dilation in mice with PET . J Nucl Med . 2005;46:1516–1521
  331. Metzler SD , Jaszczak RJ , Patil NH , et al.   Molecular imaging of small animals with a triple-head SPECT system using pinhole collimation . IEEE Trans Med Imaging . 2005;24:853–862
  332. Goertzen AL , Jones DW , Seidel J , et al.   First results from the high-resolution mouseSPECT annular scintillation camera . IEEE Trans Med Imaging . 2005;24:863–867
  333. Beekman FJ , van der Have F , Vastenhouw B , et al.   U-SPECT-I (a novel system for submillimeter-resolution tomography with radiolabeled molecules in mice) . J Nucl Med . 2005;46:1194–1200
  334. Vanhove C , Lahoutte T , Defrise M , et al.   Reproducibility of left ventricular volume and ejection fraction measurements in rat using pinhole gated SPECT . Eur J Nucl Med Mol Imaging . 2005;32:211–220
  335. Constantinesco A , Choquet P , Monassier L , et al.   Assessment of left ventricular perfusion, volumes, and motion in mice using pinhole gated SPECT . J Nucl Med . 2005;46:1005–1011
  336. Losordo DW , Vale PR , Symes JF , et al.   Gene therapy for myocardial angiogenesis (initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia) . Circulation . 1998;98:2800–2804
  337. Udelson JE , Dilsizian V , Laham RJ , et al.   Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease . Circulation . 2000;102:1605–1610
  338. Hendel RC , Henry TD , Rocha-Singh K , et al.   Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion (evidence for a dose-dependent effect) . Circulation . 2000;101:118–121
  339. Rosengart TK , Lee LY , Patel SR , et al.   Angiogenesis gene therapy (phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease) . Circulation . 1999;100:468–474
  340. Brooks P , Clark R , Cheresh D . Requirements of vascular integrin avb3 for angiogenesis . Science . 1994;264:569–571
  341. Meoli DF , Sadeghi MM , Krassilnikova S , et al.   Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction . J Clin Invest . 2004;113:1684–1691
  342. Hua J , Dobrucki LW , Sadeghi MM , et al.   Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at avb3 integrin after murine hindlimb ischemia . Circulation . 2005;111:3255–3260
  343. Pfeffer M , Braunwald E . Experimental observations and clinical implications (ventricular remodeling after myocardial infarction) . Circulation . 1990;81:1161–1172
  344. Cohn J , Ferrari R , Sharpe N . Cardiac remodeling: concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling . J Am Coll Cardiol . 2000;35:569–582
  345. Pfeffer MA , Braunwald E , Moye LA , et al.  The SAVE Investigators   Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial . N Engl J Med . 1992;327:669–677
  346. Sabbah HN , Sharov VG , Gupta RC , et al.   Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure . J Am Coll Cardiol . 2000;36:1698–1705
  347. Spinale FG . Matrix metalloproteinases (regulation and dysregulation in the failing heart) . Circ Res . 2002;90:520–530
  348. Su H , Spinale FG , Dobrucki LW , et al.   Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling . Circulation . 2005;112:3157–3167
  349. Wilson E , Moainie S , Baskin J , et al.   Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling . Circulation . 2003;107:2857–2863
  350. Chen J , Tung C-H , Allport J , et al.   Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction . Circulation . 2005;111:1800–1805
  351. Narula J , Haider N , Virmani R , et al.   Apoptosis in myocytes in end-stage heart failure . N Engl J Med . 1996;335:1182–1189
  352. Narula J , Acio ER , Narula N , et al.   Annexin-V imaging for noninvasive detection of cardiac allograft rejection . Nat Med . 2001;7:1347–1352
  353. Tuomisto TT , Binder BR , Yla-Herttuala S . Genetics, genomics and proteomics in atherosclerosis research . Ann Med . 2005;37:323–332
  354. Garcia-Touchard A , Henry TD , Sangiorgi G , et al.   Extracellular proteases in atherosclerosis and restenosis . Arterioscler Thromb Vasc Biol . 2005;25:1119–1127
  355. Hansson GK . Inflammation, atherosclerosis, and coronary artery disease . N Engl J Med . 2005;352:1685–1695
  356. Navab M , Ananthramaiah GM , Reddy ST , et al.   The oxidation hypothesis of atherogenesis (the role of oxidized phospholipids and HDL) . J Lipid Res . 2004;45:993–1007
  357. LucasAD, Greaves DR. Atherosclerosis: role of chemokines and macrophages. Exp Rev Mol Med 2001 5 November, http://www.expertreviews.org/0100369h.htm. Accessed July 5, 2006.
  358. Lees AM , Lees RS , Schoen FJ , et al.   Imaging human atherosclerosis with 99mTc-labeled low density lipoproteins . Arteriosclerosis . 1988;8:461–470
  359. Bozoky Z , Balogh L , Mathe D , et al.   Preparation and investigation of 99m technetium-labeled low-density lipoproteins in rabbits with experimentally induced hypercholesterolemia . Eur Biophys J . 2004;33:140–145
  360. Rudd JH , Warburton EA , Fryer TD , et al.   Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography . Circulation . 2002;105:2708–2711
  361. Tawakol A , Migrino RQ , Hoffmann U , et al.   Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography . J Nucl Cardiol . 2005;12:294–301
  362. Johnson LL , Schofield L , Donahay T , et al.   99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries . J Nucl Med . 2005;46:1186–1193
  363. Kolodgie FD , Petrov A , Virmani R , et al.   Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V (a technique with potential for noninvasive imaging of vulnerable plaque) . Circulation . 2003;108:3134–3139
  364. Zhou R , Thomas DH , Qiao H , et al.   In vivo detection of stem cells grafted in infarcted rat myocardium . J Nucl Med . 2005;46:816–822
  365. Chin BB , Nakamoto Y , Bulte JW , et al.   111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction . Nucl Med Commun . 2003;24:1149–1154
  366. Brenner W , Aicher A , Eckey T , et al.   111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model . J Nucl Med . 2004;45:512–518
  367. Aicher A , Brenner W , Zuhayra M , et al.   Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling . Circulation . 2003;107:2134–2139
  368. Kraitchman DL , Tatsumi M , Gilson WD , et al.   Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction . Circulation . 2005;112:1451–1461
  369. Kraitchman DL , Heldman AW , Atalar E , et al.   In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction . Circulation . 2003;107:2290–2293
  370. Benestad HB , Sundrehagen E , Rolstad B , et al.   Migration of 99mTc-labelled syngeneic lymphocytes in the rat. Biological and theoretical models predict radiation damage and poor scintigraphic detectability . J Immunol Methods . 1990;135:1–8
  371. Miyagawa M , Anton M , Haubner R , et al.   PET of cardiac transgene expression (comparison of 2 approaches based on herpesviral thymidine kinase reporter gene) . J Nucl Med . 2004;45:1917–1923
  372. Wu JC , Chen IY , Wang Y , et al.   Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium . Circulation . 2004;110:685–691
  373. Wu JC , Chen IY , Sundaresan G , et al.   Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography . Circulation . 2003;108:1302–1305
  374. Miyagawa M , Beyer M , Wagner B , et al.   Cardiac reporter gene imaging using the human sodium/iodide symporter gene . Cardiovasc Res . 2005;65:195–202
  375. Kang JH , Lee DS , Paeng JC , et al.   Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression . J Nucl Med . 2005;46:479–483
  376. Berman DS , Kang X , Hayes SW , et al.   Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management . J Am Coll Cardiol . 2003;41:1125–1133

 The authors have no conflicts of interest to disclose.

PII: S0146-2806(06)00069-7

doi: 10.1016/j.cpcardiol.2006.05.002

Current Problems in Cardiology
Volume 31, Issue 9 , Pages 557-629 , September 2006

Article Tools

* Image Usage & Resolution